# Inflammation Markers in Hyperemesis Gravidarum

> **NCT06245811** · — · COMPLETED · sponsor: **Izzet Celegen** · enrollment: 215 (actual)

## Conditions studied

- Hyperemesis Gravidarum

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06245811
- **Lead sponsor:** Izzet Celegen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-20
- **Primary completion:** 2022-03-20
- **Final completion:** 2022-06-20
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06245811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06245811, "Inflammation Markers in Hyperemesis Gravidarum". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06245811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*